|
|
 |
|
Viewing report
|
|
|
|
Barr Pharma Partnering Guide 2008
CurrentPartnering, July 2008, Pages: 47
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Bigpharma – The Top 50
Chapter 3 – Most active bigpharma dealmakers
3.1 Bigpharma M&A activity
3.2 Bigpharma partnering
Chapter 4 – Top bigpharma deals – 2000-7
4.1 Bigpharma M&A
4.2 Bigpharma partnering
Chapter 5 – Submitting Opportunities to Bigpharma such as Barr Pharmaceuticals
5.1 How to submit an opportunity
5.2 Opportunity submission template
5.3 Sending emails
5.4 Face to face at partnering events
5.5 Online submission forms
Chapter 6 – Forthcoming bigpharma partnering events
6.1 Forthcoming events
Chapter 7 – Barr Pharmaceuticals – therapy locator
7.1 How to use the therapy matrix tables
7.2 Therapeutic area definitions
7.3 Bigpharma – Therapeutic target matrix – marketed and pipeline compounds
7.5 Bigpharma – Therapeutic target matrix – expressed partnering interests
7.6 Bigpharma – Therapeutic target matrix – recent deals – 2005-2007
Chapter 8 – Bigpharma Company Profiles
8.1 How to use company profiles
8.2 Field definitions
8.3 Barr Pharmaceuticals company profile
Company contact details
Subsidiary companies
Primary therapy areas
Business development contacts
Company description
Marketed therapeutic indications
Pipeline (phase I-III) therapeutic indications
Partnering interests
Partnering interests - therapeutic indications
Partnering frequency per annum - 2000-2008
Current partner companies (2005-8)
Recent deals 2005-2008
By deal type
By stage of development
By therapy area
Contract documents available online - link direct to each document
Figures in report:
Figure 1: Bigpharma – top 50 by pharma revenues 2007
Figure 2: Leading Bigpharma M&A companies, 2005-7
Figure 3: Leading Bigpharma partnering companies, 2005-7
Figure 4: Leading M&A deals involving bigpharma by value, 2005-7
Figure 5: Leading partnering deals by value, 2005-7
Figure 6: Typical partnering opportunity submission template
Figure 7: Partnering events 2008-9
Figure 8: Therapeutic area definitions
Figure 9: Therapeutic target matrix – marketed and pipeline compounds
Figure 10: Therapeutic target matrix – expressed partnering interests
Figure 11: Therapeutic target matrix – recent deals 2005-7
Figure 12: Company profile template and definitions used in report
Figure 13: Barr – Dealmaking frequency 2000-2007
Figure 14: Barr - recent deals (2005-2008) by deal type
Figure 15: Barr - recent deals (2005 – 2008) by stage of development
Figure 16: Barr – recent deals (2005 – 2008) by therapy area
Figure 17: Recent Barr partnering deals (2003-2008) where contract document available
Figure 18: Online partnering resources
Customers who bought this item also bought
Pre-clinical Stage Partnering Agreements in Biopharma
Discovery Stage Partnering Agreements in Biopharma
Partnering in the Global Generics Industry 2008: A Guide to Companies
Barr Pharmaceuticals Inc Deals Briefing
Option and Evaluation Agreements in Pharma and Biotech
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Central Nervous System - Insomnia or Sleep Disorders Drug Pipeline Report
Co-promotion and Co-marketing Agreements in Biopharma, 2nd Edition
Global Generics Guide 3rd Edition: Benchmarking Generics Company Capabilities and Strategy
Emerging Generic Drug Companies Worldwide 2007
|
|
|
|
